(Q39937997)

15 September 2017

1 reference

title

Structure-activity relationships in coumermycins (English)

1 reference

15 September 2017

Godfrey JC

1

1 reference

PubMed ID

4593293

15 September 2017

Price KE

series ordinal

2

1 reference

15 September 2017

1 January 1972

1 reference

Advances in Applied Microbiology

15 September 2017

1 reference

15 September 2017

15

1 reference

15 September 2017

231-296

1 reference

Effect of novobiocin on permeability of Escherichia coli

15 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2164%2808%2970094-7

7 January 2021

The Effect of Coumermycin A1on the Meningococcal Carrier State

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2164%2808%2970094-7

7 January 2021

Activity of alpha-phenoxyalkyl penicillins against sensitive and resisant Staphylococci

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2164%2808%2970094-7

7 January 2021

Prediction of antimeningococcic chemoprophylactic efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2164%2808%2970094-7

7 January 2021

Pharmacokinetic profile of coumermycin A

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2164%2808%2970094-7

7 January 2021

Structure-activity relationships in chemically modified coumermycin

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2164%2808%2970094-7

7 January 2021

In Vitro Studies of the Activity of Coumermycin-A1 against Staphylococci Resistant to Methicillin and Cephalothin

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2164%2808%2970094-7

7 January 2021

Coumermycin A1—Biopharmaceutical Studies I

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2164%2808%2970094-7

7 January 2021

Coumermycin A1-Biopharmaceutical studies. II.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2164%2808%2970094-7

7 January 2021

10.1016/S0065-2164(08)70094-7

Identifiers

DOI

0 references

PubMed ID

4593293

1 reference

PubMed ID

4593293